All In MedTech

FDA Clearance Tracker · P030011-S001

SYNCARDIA TEMPORARY CARDIOWEST TOTAL ARTIFICIAL HEART (TAH-T)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 26, 2005 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P030011-S001
Device name
SYNCARDIA TEMPORARY CARDIOWEST TOTAL ARTIFICIAL HEART (TAH-T)
Applicant location
Tucson, AZ
Received
May 10, 2005
Decided
Oct 26, 2005
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P030011

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code LOZ

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY FOR THE DEVICE.

Source documents

Other decisions for Syncardia Systems, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.